- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/429 - Thiazoles condensed with heterocyclic ring systems
Patent holdings for IPC class A61K 31/429
Total number of patents in this class: 787
10-year publication summary
|
41
|
44
|
48
|
33
|
38
|
32
|
45
|
41
|
59
|
27
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7841 |
14 |
| Bristol-myers Squibb Company | 4815 |
12 |
| The Regents of the University of California | 20587 |
12 |
| University of Florida Research Foundation, Inc. | 4154 |
11 |
| Merck Sharp & Dohme Corp. | 2184 |
9 |
| Merck Patent GmbH | 5669 |
9 |
| Takeda Pharmaceutical Company Limited | 2716 |
9 |
| Ambit Biosciences Corporation | 54 |
9 |
| Genentech, Inc. | 4087 |
8 |
| Donaghys Limited | 27 |
8 |
| Anima Biotech Inc. | 38 |
8 |
| Boehringer Ingelheim International GmbH | 4496 |
7 |
| Janssen Pharmaceutica N.V. | 3226 |
7 |
| Alectos Therapeutics Inc. | 45 |
7 |
| Carna Biosciences, Inc. | 66 |
7 |
| Colorado State University Research Foundation | 715 |
7 |
| Daiichi Sankyo Company, Limited | 1892 |
7 |
| Dana-Farber Cancer Institute, Inc. | 2654 |
7 |
| Hangzhou Synrx Therapeutics Biomedical Technology Co., Ltd. | 15 |
7 |
| Novartis AG | 10341 |
6 |
| Other owners | 616 |